Treatment naïve participants sofosbuvir/ledipasvir, oral, 400mg/90mg once daily for 8 or 12 wks; or sofosbuvir/ledipasvir,
oral, 400mg/90mg once daily, with
ribavirin, 500mg or 600mg twice daily for 8 wks;
Treatment experienced participants sofosbuvir/ledipasvir, oral, 400mg/90mg once daily for 12 wks; or sofosbuvir/ledipasvir, oral, 400mg/90mg once daily, with ribavirin, 500mg or 600mg twice daily for 12 wks.
Follow-up: Active treatment period up to 12 wks; 3 yrs follow-up.